{"schema_version":"secwatch.filing_event.v1","accession":"0001609550-26-000006","form_type":"8-K","ticker":"INSP","cik":"0001609550","company_name":"Inspire Medical Systems, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.635540+00:00","generated_at":"2026-05-16T10:52:44.542449+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Inspire Medical posts preliminary Q4 rev ~$269M (+12% YoY); 2026 guidance $1,003-1,013M","bullets":["Preliminary Q4 2025 revenue ~$269M, up 12% YoY; full-year 2025 revenue ~$912M, up 14% YoY.","Initial FY 2026 revenue guidance of $1,003M-$1,013M, implying 10-11% growth over 2025.","Appointed Matt Osberg as EVP and CFO, start Jan 19, 2026; base salary $650k, sign-on $600k, equity awards $3M.","Rick Buchholz steps down as CFO, serves as interim CFO through filing of 2025 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001609550-26-000006","json":"https://secwatch.observer/filing/0001609550-26-000006.json","markdown":"https://secwatch.observer/filing/0001609550-26-000006.md","text":"https://secwatch.observer/filing/0001609550-26-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609550/000160955026000006/0001609550-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609550/000160955026000006/insp-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:52:44.542449+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}